ROLE OF METABOLIC THERAPY IN TREATMENT OF MYOCARDIUM DYSTROPHY IN CHILDREN
The objective of present research was studying of influence of co-enzyme Q10 (Kudesan) on cardiovascular system in children with myocardial dystrophy (MCD). Patients were divided on two comparable groups (n = 20 and n = 28) according to clinical symptoms of MCD, changes on electrocardiogram (ECG) an...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2010-09-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/943 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The objective of present research was studying of influence of co-enzyme Q10 (Kudesan) on cardiovascular system in children with myocardial dystrophy (MCD). Patients were divided on two comparable groups (n = 20 and n = 28) according to clinical symptoms of MCD, changes on electrocardiogram (ECG) and results of echocardiography. Patients received non-drug means (massage, physical training in treatment regimen, psycho- and reflexotherapy) and vasoactive, nootropic and sedative medications; patients from 2nd group were additionally treated with co-enzyme Q10 during 4 weeks. It was shown that inclusion of co-enzyme Q10 in complex treatment of MCD resulted in beneficial effect on self-feeling of child, favored to disappearance of repolarization disorders on ECG and increase of ejectional fraction. Thus, using of co-enzyme Q10 in complex treatment of children with MCD is reasonable. Key words: children, myocardial dystrophy, co-enzyme Q10, treatment.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2010;9(5):18-23) |
|---|---|
| ISSN: | 1682-5527 1682-5535 |